D. Thiboutot

发表

Erratum to: New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Sewon Kang, A. Finlay, B. Dréno, 2016, Dermatology and Therapy.

A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.

Z. Draelos, D. Thiboutot, A. Shalita, 2012, Cutis.

Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.

Sewon Kang, D. Thiboutot, J. Weiss, 2007, Journal of the American Academy of Dermatology.

Efficacy of an oral contraceptive containing EE 0.03mg and CMA 2mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

D. Thiboutot, 2010 .

Acne. An overview of clinical research findings.

D. Thiboutot, 1997, Dermatologic clinics.

Changing the Wound Healing Landscape — Offloading Stress , Aiding Stem Cells

M. Lebwohl, R. Kirsner, W. Steele, 2014 .

Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients

E. Wolpert, D. Thiboutot, A. Nelson, 2012, The Journal of investigative dermatology.

Histone H4 is a major component of the antimicrobial action of human sebocytes.

Chun-Ming Huang, M. Monestier, D. Thiboutot, 2009, The Journal of investigative dermatology.

The hypothetical role of FoxO1 in acne is interesting, but more study is needed before any conclusions can be drawn

J. Leyden, B. Dréno, H. Gollnick, 2010, The British journal of dermatology.

Cutaneous androgen metabolism: basic research and clinical perspectives.

C. Zouboulis, D. Thiboutot, WenChieh Chen, 2002, The Journal of investigative dermatology.

Artificial Intelligence for the Objective Evaluation of Acne Investigator Global Assessment.

Francesco Amato, Carlo Cosentino, Andrea Cherubini, 2018, Journal of drugs in dermatology : JDD.

Assessing effectiveness in acne clinical trials: steps towards a core outcome measure set

M. Chren, A. Layton, D. Thiboutot, 2019, The British journal of dermatology.

Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne.

J. Yoon, Ji Yong Park, Yun-Sang Lee, 2015, The Journal of investigative dermatology.

Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action

D. Thiboutot, Wei Zhao, A. Zaenglein, 2009, Dermato-endocrinology.

Update and Future of Hormonal Therapy in Acne

D. Thiboutot, WenChieh Chen, 2003, Dermatology.

Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.

J. Yoon, D. Thiboutot, H. Kwon, 2013, The Journal of investigative dermatology.

Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel

M. Schaller, M. Steinhoff, A. Bewley, 2017, The British journal of dermatology.

Hormonal therapy for acne.

D. Thiboutot, Rosalyn George, Shari B. Clarke, 2008, Seminars in cutaneous medicine and surgery.

Activity of type 1 5α–reductase is greater in the follicular infrainfundibulum compared with the epidermis

D. Thiboutot, H. Knaggs, K. Gilliland, 1997, The British journal of dermatology.

Multiscale analysis of acne connects molecular subnetworks with disease status

Jacob B. Hall, Aparna A. Divaraniya, E. Schadt, 2019, bioRxiv.

IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway.

G. Clawson, D. Thiboutot, K. Gilliland, 2008, The Journal of investigative dermatology.

Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

S. Amin, G. Perdew, I. Murray, 2019, Toxicological sciences : an official journal of the Society of Toxicology.

GI Polyposis and Glycogenic Acanthosis of the Esophagus Associated With PTEN Mutation Positive Cowden Syndrome in the Absence of Cutaneous Manifestations

C. Eng, H. Hampel, D. Thiboutot, 2003, American Journal of Gastroenterology.

Hormonal Therapy for Acne

D. Thiboutot, D. Marcoux, 1996, Seminars in cutaneous medicine and surgery.

Consumption of dairy in teenagers with and without acne.

A. Kunselman, D. Thiboutot, Junjia Zhu, 2016, Journal of the American Academy of Dermatology.

Inhibition of Sebum Production with the Acetyl Coenzyme A Carboxylase Inhibitor Olumacostat Glasaretil.

H. Hofland, R. Brownsey, D. Thiboutot, 2017, The Journal of investigative dermatology.

Peroxisome proliferator-activated receptors increase human sebum production.

R. Gabbay, D. Thiboutot, D. Mauger, 2006, The Journal of investigative dermatology.

The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells.

G. Clawson, D. Thiboutot, K. Gilliland, 2000, The Journal of investigative dermatology.

Standard Management Options for Rosacea: the 2019 Update by the National Rosacea Society Expert Committee.

M. Macsai, Sewon Kang, Jerry Tan, 2020, Journal of American Academy of Dermatology.

Shortcomings in rosacea diagnosis and classification

J. Leyden, M. Schaller, M. Steinhoff, 2017, The British journal of dermatology.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.

D. Thiboutot, R. Gallo, L. Eichenfield, 2013, Cutis.

Standard management options for rosacea, part 1: overview and broad spectrum of care.

M. Macsai, J. Dover, D. Thiboutot, 2009, Cutis.

Developing a Core Outcome Set for Acne Clinical Trials: Towards Standardization and Harmonization

Jerry Tan, D. Thiboutot, A. Layton, 2021, Acne.

Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1).

G. Clawson, D. Thiboutot, J. McAllister, 2003, The Journal of investigative dermatology.

Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin.

D. Thiboutot, G. Harris, K. Gilliland, 1995, The Journal of investigative dermatology.

Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne

D. Thiboutot, A. Mazzetti, M. Gerloni, 2020, JAMA dermatology.

Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.

J. Barbieri, H. Gollnick, Sewon Kang, 2022, JAMA dermatology.

Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris: A Systematic Review of Measure Development and Measurement Properties.

J. Barbieri, D. Thiboutot, Z. Hopkins, 2022, JAMA dermatology.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.

D. Thiboutot, R. Gallo, G. Webster, 2013, Cutis.

Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee.

Sewon Kang, M. Steinhoff, M. Mannis, 2018, Journal of the American Academy of Dermatology.

Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women.

D. Thiboutot, D. Mauger, M. Cappel, 2005, Archives of Dermatology.

Androgen metabolism in sebaceous glands from subjects with and without acne.

D. Thiboutot, D. Lookingbill, K. Gilliland, 1999, Archives of dermatology.

Evidence‐based recommendations for the management of acne fulminans and its variants

J. Leyden, M. Levin, D. Thiboutot, 2017, Journal of the American Academy of Dermatology.

Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial.

D. Thiboutot, A. Lucky, M. Niknian, 2008, Contraception.

Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.

D. Thiboutot, A. Nelson, Rosalyn George, 2007, Dermatologic clinics.

Standard management options for rosacea, part 2: options according to subtype.

M. Macsai, J. Dover, D. Thiboutot, 2009, Cutis.

A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.

J. Kirby, D. Thiboutot, D. Leslie, 2014, Journal of the American Academy of Dermatology.

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.

J. Waldstreicher, D. Thiboutot, L. Drake, 1999, Journal of the American Academy of Dermatology.

Antimicrobial Activity of Sebocytes against Propionibacterium acnes via Toll-Like Receptor 2 and Lysosomal Pathway.

M. Qin, D. Thiboutot, G. Agak, 2016, The Journal of investigative dermatology.

Improving outcomes through collaboration.

D. Thiboutot, J. Harper, S. Sondheimer, 2008, Cutis.

Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel†

M. Schaller, A. Bewley, M. Mannis, 2019, British Journal of Dermatology.

Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.

D. Thiboutot, R. Gallo, L. Eichenfield, 2013, Cutis.

Keeping the peace: commensal Cutibacterium acnes trains CD4+ TH17 cells to trap and kill.

D. Thiboutot, A. Nelson, 2021, The Journal of clinical investigation.

Isolation and Identification of the Follicular Microbiome: Implications for Acne Research.

Jacob B. Hall, J. Dudley, B. Kidd, 2017, The Journal of investigative dermatology.

Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

D. Thiboutot, R. Gallo, G. Webster, 2019, The Journal of clinical and aesthetic dermatology.

A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.

A. Fleischer, D. Thiboutot, J. D. Del Rosso, 2009, Journal of drugs in dermatology : JDD.

13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes.

D. Thiboutot, A. Nelson, K. Gilliland, 2006, The Journal of investigative dermatology.

Isotretinoin temporally regulates distinct sets of genes in patient skin.

D. Thiboutot, Wei Zhao, A. Zaenglein, 2009, The Journal of investigative dermatology.

G2A Attenuates Propionibacterium acnes Induction of Inflammatory Cytokines in Human Monocytes

M. Qin, D. Thiboutot, L. J. Marinelli, 2017, Annals of dermatology.

IL-17: a key player in the P. acnes inflammatory cascade?

A. Layton, D. Thiboutot, E. Anne Eady, 2014, The Journal of investigative dermatology.

Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.

D. Thiboutot, R. Gallo, L. Kircik, 2012, Journal of drugs in dermatology : JDD.

Emerging therapies in rosacea.

A. Layton, D. Thiboutot, 2013, Journal of the American Academy of Dermatology.

Hormonal Influences in Acne: Part II: Acne Treatments

D. Thiboutot, 2007 .

Acne: hormonal concepts and therapy.

D. Thiboutot, 2004, Clinics in dermatology.

Hormones and acne: pathophysiology, clinical evaluation, and therapies.

D. Thiboutot, 2001, Seminars in cutaneous medicine and surgery.

Immunolocalization of 5alpha-reductase isozymes in acne lesions and normal skin.

D. Thiboutot, J. Thorne, K. Helm, 2000, Archives of dermatology.

Activity of 5-Alpha-Reductase and 17-Beta-Hydroxysteroid Dehydrogenase in the Infrainfundibulum of Subjects with and without Acne vulgaris

D. Thiboutot, H. Knaggs, K. Gilliland, 1998, Dermatology.

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.

R. Thieroff-Ekerdt, D. Thiboutot, K. Graupe, 2003, Journal of the American Academy of Dermatology.

Acne severity grading: determining essential clinical components and features using a Delphi consensus.

M. Chren, J. Leyden, Jerry Tan, 2012, Journal of the American Academy of Dermatology.

Diagnosing and managing the patient with rosacea.

D. Thiboutot, C. Mackley, 2005, Cutis.

Pathogenesis of acne: recent research advances.

D. Thiboutot, J. Harper, 2003, Advances in dermatology.

Expert Committee Recommendations for Acne Management

D. Thiboutot, A. Zaenglein, 2006, Pediatrics.

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

H. Gollnick, W. Cunliffe, J. Leyden, 2003, Journal of the American Academy of Dermatology.

Oxidative activity of the type 2 isozyme of 17β-hydroxysteroid dehydrogenase (17β-HSD) predominates in human sebaceous glands

D. Thiboutot, Patricia Martin, K. Gilliland, 1998 .

TRAIL contributes to the apoptotic effect of 13‐cis retinoic acid in human sebaceous gland cells

D. Thiboutot, A. Nelson, K. Gilliland, 2011, The British journal of dermatology.

The Personalised Acne Care Pathway—Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations.

S. Feldman, L. Goldsmith, J. Callen, 2004, Journal of the American Academy of Dermatology.

A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment

D. Thiboutot, D. Archer, A. Lemay, 2001 .

Refractory Acne and 21-Hydroxylase Deficiency in a Selected Group of Female Patients

D. Thiboutot, 2011 .

Identifying the Impacts of Acne: A Delphi Survey of Patients and Clinicians

M. Frey, Jerry Tan, A. Layton, 2020, Journal of cutaneous medicine and surgery.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Dermatologists do not yet fully understand the clinical significance of antibiotic use and bacterial resistance in patients with acne: comment on "Antibiotics, acne, and Staphylococcus aureus colonization.

D. Thiboutot, 2011, Archives of dermatology.

Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?

D. Thiboutot, J. D. Del Rosso, 2013, The Journal of clinical and aesthetic dermatology.

Standardized laboratory monitoring with use of isotretinoin in acne.

J. Kirby, D. Thiboutot, T. Hansen, 2016, Journal of the American Academy of Dermatology.

Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.

Jerry Tan, A. Layton, D. Thiboutot, 2017, The Journal of investigative dermatology.

The effects of isotretinoin on wisdom tooth extraction.

D. Thiboutot, A. Zaenglein, J. Sharma, 2012, Journal of American Academy of Dermatology.

Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action

D. Thiboutot, Wei Zhao, A. Zaenglein, 2009, Dermato-endocrinology.

Acne: acute or chronic disease?

D. Thiboutot, D. Lookingbill, 1995, Journal of the American Academy of Dermatology.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

J. Manson, G. Colditz, N. Boyd, 2010, The Journal of clinical endocrinology and metabolism.

Over‐the‐Counter Acne Treatments

E. Graber, D. Thiboutot, 2015, Cosmetic Dermatology.

New treatments and therapeutic strategies for acne.

D. Thiboutot, Diane Thiboutot, 2000, Archives of family medicine.

Occupationally induced allergic contact dermatitis to methylchloroisothiazolinone/methylisothiazolinone among machinists.

D. Thiboutot, J. Marks, S. D. Madden, 1994, Journal of the American Academy of Dermatology.

Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne abstract Acne vulgaris is one of the most common skin con-

S. Orlow, K. Vaux, D. Thiboutot, 2016 .

Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne

S. Orlow, K. Vaux, D. Thiboutot, 2013, Pediatrics.

Acne Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric

S. Orlow, K. Vaux, D. Thiboutot, 2013 .

Contact Dermatitis From Printing Inks

D. Thiboutot, J. Marks, D. Vasily, 1992 .

Acne and rosacea. New and emerging therapies.

D. Thiboutot, 2000, Dermatologic clinics.

Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.

S. Tyring, D. Thiboutot, L. Kircik, 2016, The Journal of clinical and aesthetic dermatology.

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

H. Gollnick, J. Leyden, Sewon Kang, 2009, Journal of the American Academy of Dermatology.

Finasteride in the treatment of men with frontal male pattern hair loss.

M. Lebwohl, J. Leyden, J. Waldstreicher, 1999, Journal of the American Academy of Dermatology.

Dermatoses among floral shop workers.

B. Hamory, D. Thiboutot, J. Marks, 1990, Journal of the American Academy of Dermatology.

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.

D. Thiboutot, J. Weiss, G. Webster, 2008, Journal of the American Academy of Dermatology.

Cytomegalovirus diaper dermatitis.

D. Thiboutot, M. Maloney, C. Mart, 1991, Archives of dermatology.

Large‐scale worldwide observational study of adherence with acne therapy

H. Gollnick, J. Leyden, A. Finlay, 2010, International journal of dermatology.

An overview of acne and its treatment.

D. Thiboutot, Diane Thiboutot, 1996, Cutis.

Can sebum reduction predict acne outcome?

D. Thiboutot, J. Harness, J. Cook, 2010, The British journal of dermatology.

Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.

M. Gold, D. Kaplan, D. Thiboutot, 2001, Cutis.

Guidelines of care for acne vulgaris management.

J. Strauss, J. Leyden, D. Thiboutot, 2007, Journal of the American Academy of Dermatology.

A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris.

D. Thiboutot, P. Rich, Michael Jarratt, 2002, Clinical therapeutics.

Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling.

D. Thiboutot, Wei Zhao, Diane M Thiboutot, 2006, The Journal of investigative dermatology.

Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6/E7 RNA

N. Christensen, G. Clawson, D. Thiboutot, 2004, Gene Therapy.

Antibiotic stewardship in dermatology: limiting antibiotic use in acne

H. Gollnick, J. Leyden, Sewon Kang, 2014, European Journal of Dermatology.

Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing,

J. Leyden, D. Thiboutot, R. Gallo, 2016, The Journal of clinical and aesthetic dermatology.

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne

H. Gollnick, J. Leyden, Sewon Kang, 2018, Journal of the American Academy of Dermatology.

Immunolocalization of 5α-Reductase Isozymes in Acne Lesions and Normal Skin

Diane Thiboutot, D. Thiboutot, J. Thorne, 2000 .

Letter to the Editor From Singh et al: “Female Adult Acne and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee”

J. Barbieri, William D James, D. Thiboutot, 2022, Journal of the Endocrine Society.

Changes in the management of acne: 2009-2019.

H. Gollnick, B. Dréno, D. Thiboutot, 2020, Journal of the American Academy of Dermatology.

Understanding innate immunity and inflammation in acne: implications for management

J. Leyden, B. Dréno, H. Gollnick, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Regulation of human sebaceous glands.

D. Thiboutot, 2004, The Journal of investigative dermatology.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Reviewing the global burden of acne: how could we improve care to reduce the burden? *

D. Thiboutot, J. Tan, A. Layton, 2020, The British journal of dermatology.

Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.

J. Herndon, Y. Poulin, D. Thiboutot, 2006, Journal of the American Academy of Dermatology.

The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.

D. Thiboutot, T. Jones, S. Clark, 2005, Cutis.

Diet and acne revisited.

J. Strauss, D. Thiboutot, 2002, Archives of dermatology.

Changing the face of acne therapy.

J. Leyden, Sewon Kang, D. Thiboutot, 2009, Cutis.

Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients

T. Abraham, R. Neves, G. Matters, 2015, PloS one.

Large‐scale international study enhances understanding of an emerging acne population: adult females

B. Dréno, D. Thiboutot, D. Berson, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells.

D. Thiboutot, Wei Zhao, A. Zaenglein, 2008, The Journal of clinical investigation.

Hormonal therapies for acne.

D. Thiboutot, B. Barros, 2017, Clinics in dermatology.

Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications.

D. Thiboutot, L. Kircik, L. Stein Gold, 2020, Journal of drugs in dermatology : JDD.

A systemic type I 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris

A. Gottlieb, J. Strauss, Sewon Kang, 2004 .

Development of a Comprehensive Quality-of-Life Measure for Facial and Torso Acne

M. Chren, M. Frey, Jerry Tan, 2018, Journal of cutaneous medicine and surgery.

Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.

D. Thiboutot, G. Webster, E. Merikle, 2010, Cutis.

Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials

J. Waldstreicher, D. Thiboutot, S. Hartmaier, 1996, Quality of Life Research.

Building a System to Engage and Sustain Research Careers for Physicians.

R. Mailman, D. Thiboutot, S. Dovat, 2020, Academic medicine : journal of the Association of American Medical Colleges.

A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms

D. Thiboutot, 2012 .

Circulating Tumor Cells in Melanoma Patients

A. Berg, R. Neves, G. Clawson, 2012, PloS one.

What Matters the Most to Adult Women With Acne?

A. Layton, D. Thiboutot, A. Zaenglein, 2021, JAMA dermatology.

Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel

M. Schaller, M. Steinhoff, A. Bewley, 2017, The British journal of dermatology.

D. Thiboutot, C. Girman, A. Martin, 2001, Clinical and experimental dermatology.

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.

J. Leyden, D. Thiboutot, A. Shalita, 2004, Clinical therapeutics.

A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults.

A. Fleischer, J. Leyden, D. Thiboutot, 2007, Cutis.

Interstitial granulomatous dermatitis with arthritis.

D. Thiboutot, D. Vasily, K. Helm, 1996, Journal of the American Academy of Dermatology.

Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream

D. Thiboutot, 2012 .

Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri.

Grace K. Kim, D. Thiboutot, G. Webster, 2016, JAMA dermatology.

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.

Sewon Kang, S. Arsonnaud, D. Thiboutot, 2006, Archives of dermatology.

Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1.

G. Clawson, D. Thiboutot, K. Gilliland, 2006, The Journal of investigative dermatology.

A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.

D. Thiboutot, A. Lucky, M. Niknian, 2008, Cutis.

A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.

D. Thiboutot, D. Archer, A. Lemay, 2001, Fertility and sterility.

LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations

J. Leyden, M. Levin, D. Thiboutot, 2016 .

Oral isotretinoin and pregnancy prevention programmes

J. Leyden, B. Dréno, H. Gollnick, 2012, The British journal of dermatology.

iPLEDGE: A Report from the Front Lines of Dermatologic Practice.

C. Cockerell, D. Thiboutot, 2006, The virtual mentor : VM.

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Sewon Kang, A. Finlay, B. Dréno, 2016, Dermatologic Therapy.

Development of an atrophic acne scar risk assessment tool

J. Leyden, B. Dréno, H. Gollnick, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Overview of acne and its treatment.

D. Thiboutot, 2008, Cutis.

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.

Sewon Kang, S. Arsonnaud, D. Thiboutot, 2005, Skinmed.

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

B. Strober, J. Leyden, D. Thiboutot, 2006, Archives of dermatology.

Updates in Isotretinoin

D. Thiboutot, Katherine A. Berry, Katherine K. Hallock, 2021, Acne.

Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism

D. Thiboutot, 2011 .

Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.

D. Thiboutot, Susun Bellew, J. D. Del Rosso, 2011, Journal of drugs in dermatology : JDD.

Pharmacokinetics of Dapsone Gel, 5% for the Treatment of Acne Vulgaris

D. Thiboutot, R. Halder, S. Garrett, 2007, Clinical pharmacokinetics.

Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review

Georgina L Jones, Jerry Tan, A. Layton, 2020, American Journal of Clinical Dermatology.

An Overview of Clinical Research Findings

D. Thiboutot, 1997 .

Dermabrasion for Acne Scars During Treatment with Oral Isotretinoin

D. Thiboutot, 2011 .

Acne counseling to improve adherence.

B. Dréno, A. Layton, D. Thiboutot, 2008, Cutis.

Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee

Diane Thiboutot, Sewon Kang, M. Steinhoff, 2018, Journal of the American Academy of Dermatology.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea.

A. Fleischer, D. Thiboutot, J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.

B. Elewski, A. Fleischer, Z. Draelos, 2006, Cutis.

Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp.

D. Thiboutot, D. Whiting, G. Harris, 1999, British Journal of Dermatology.

Immunolocalization of 5a-Reductase Isozymes in Acne Lesions and Normal Skin

D. Thiboutot, J. Thorne, K. Helm, 2000 .

Propecia dosages [3]

D. Thiboutot, 1999 .

A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne.

D. Thiboutot, A. Shalita, L. Eichenfield, 2009, The Journal of clinical and aesthetic dermatology.

Industry-Sponsored “Expert Committee Recommendations for Acne Management” Promote Expensive Drugs on the Basis of Weak Evidence: In Reply

D. Thiboutot, A. Zaenglein, 2007, Pediatrics.

Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.

D. Thiboutot, L. Kircik, E. Tanghetti, 2009, Journal of drugs in dermatology : JDD.

A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.

D. Thiboutot, A. Shalita, L. Eichenfield, 2009, Cutis.

Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.

S. Arsonnaud, D. Thiboutot, P. Soto, 2008, Journal of drugs in dermatology : JDD.

Long-term safety and efficacy study of adapalene 0.3% gel.

D. Thiboutot, J. Weiss, Yin Liu, 2008, Journal of Drugs in Dermatology.

Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris.

D. Thiboutot, 2008, Journal of drugs in dermatology : JDD.

Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.

J. Leyden, D. Thiboutot, A. Shalita, 2005, Clinical therapeutics.

Differences in Acne Treatment Prescribing Patterns of Pediatricians and Dermatologists: An Analysis of Nationally Representative Data

D. Thiboutot, 2010 .

COMPARISON OF A 3-STEP ACNE SYSTEM CONTAINING SOLUBILIZED BENZOYL PEROXIDE VERSUS BENZOYL PEROXIDE/CLINDAMYCIN: A MULTICENTER, INVESTIGATOR-BLIND, RANDOMIZED STUDY

D. Thiboutot, A. Shalita, L. Eichenfield, 2008 .

Inflammasome activation by Propionibacterium acnes: the story of IL-1 in acne continues to unfold.

D. Thiboutot, 2014, The Journal of investigative dermatology.

Clinical review 74: Dermatological manifestations of endocrine disorders.

D. Thiboutot, 1995, The Journal of clinical endocrinology and metabolism.

A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.

J. Dover, Z. Draelos, M. Gold, 2013, Journal of Drugs in Dermatology.

Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea.

J. Leyden, D. Thiboutot, A. Shalita, 2004, Cutis.

Dermatological applications of high-frequency ultrasound

Diane Thiboutot, D. Thiboutot, 1999, Medical Imaging.

Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne.

D. Thiboutot, N. Craft, C. Loesche, 2022, Journal of dermatological treatment (Print).

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

J. Manson, G. Colditz, N. Boyd, 2010, The Journal of clinical endocrinology and metabolism.

The role of follicular hyperkeratinization in acne

D. Thiboutot, D. Thiboutot, 2000 .

A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris.

A. Gottlieb, J. Strauss, Sewon Kang, 2004, Journal of American Academy of Dermatology.

Immunohistochemical localization of types 1 and 2 5α‐reductase in human scalp

Harris, J. Flanagan, D. Thiboutot, 1999, The British journal of dermatology.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Standard management options for rosacea, part 2: options according to subtype.

M. Macsai, J. Dover, D. Thiboutot, 2009, Cutis.

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Standard management options for rosacea, part 1: overview and broad spectrum of care.

M. Macsai, J. Dover, D. Thiboutot, 2009, Cutis.

Development of an atrophic acne scar risk assessment tool

B. Dréno, D. Thiboutot, J. Guillemot, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Selective Rho Kinase Inhibitor Allows for Expansion of Human Primary Sebocytes In Vitro.

D. Thiboutot, M. Moll, A. Nelson, 2016, Journal of Investigative Dermatology.